Pasteurized donor human milk (PDHM) is associated with a reduced incidence of necrotizing enterocolitis in very low birth weight (VLBW) infants. Absence of Medicaid and private insurance payment for PDHM use in neonatal intensive care units contributes to disparities based on state of birth and socioeconomic level. Before 2017, 5 states had policies for PDHM coverage, incorporating less than 30% of VLBW infants born nationally. In this case study, we outline the partnership of local American Academy of Pediatrics (AAP) chapters with the national AAP Section on Neonatal-Perinatal Medicine to create a PDHM Advocacy Toolkit to facilitate Medicaid PDHM coverage. Over 5 years, neonatologist-led advocacy, incentivized via AAP funds, contributed to 5 additional states providing Medicaid payment for PDHM, resulting in over 55% of VLBW infants born nationally in states with funded coverage. Partnerships with state AAP chapters, pilot grant funding with deliverables, emphasis on advocacy coaching, and modification of the generalized toolkit to suit local needs were essential in engineering Medicaid PDHM payment. Together these actions provide a template for other pediatric subspecialists to help advance niche-focused advocacy issues at the state level.

Pasteurized donor human milk (PDHM) is associated with a reduced incidence of necrotizing enterocolitis (NEC) in very low birth weight (VLBW) infants.16  NEC is a significant comorbidity of preterm birth, affecting 10% of very low birth weight infants with up to 50% mortality.710  Survivors of NEC experience both short and long-term complications, including prolonged NICU stay, liver failure, short gut syndrome, cholestasis, and poor growth.11  Further, NEC is associated with poor cognitive and motor outcomes in early childhood.12  Management of NEC incurs significant expense—with each case costing an estimated $300 000 to $500 000 depending on severity of disease and need for surgical intervention.1315  Though the pathogenesis of the disease is multifactorial and not fully understood, type of enteral feeding is associated with NEC in premature infants.1618  Maternal breast milk is the preferred feeding type for premature infants and decreases the odds of developing NEC compared with cow’s milk-based formula.19  However, when maternal breast milk is unavailable, the American Academy of Pediatrics (AAP) recommends pasteurized donor human milk (PDHM) as the second-best option.1  Several studies have demonstrated a reduced incidence of medical and surgical NEC with PDHM use in high-risk populations.26 

However, absence of third-party payment for PDHM, limited availability, and varying state rules regarding classification of PDHM as a nutritional or biologic item (which may require a state-sponsored tissue-banking license for administration) create barriers to implementation in NICUs nationwide.20  Decreased PDHM availability for babies cared for in safety-net hospitals, and increased use among parents of higher socioeconomic status, who independently purchase PDHM, contribute to a significant neonatal healthcare disparity.21  In 2015, New York Chapter 2 of the AAP, in partnership with the AAP Section on Neonatal-Perinatal Medicine (AAP SONPM) submitted a national resolution to the AAP’s annual leadership forum calling for Medicaid and private-payer coverage for PDHM for very low birth weight (VLBW) infants and for efforts to reduce racial, ethnic, and socioeconomic discrepancies in access.22  At the time, only Texas, Missouri, and California offered significant state-based Medicaid reimbursement.21  This case study describes the partnership of the AAP SONPM and New York Chapter 2 of the AAP to promote state-based Medicaid coverage of PDHM nationwide. More broadly, this case describes a strategy by which subspecialty organizations can use existing state child advocacy infrastructure to achieve goals normally not at the forefront of local AAP chapters, whose advocacy priorities orient toward general pediatric issues.

New York Chapter 2 is 1 of 3 AAP chapters within New York State. The chapter includes 2 suburban counties, Nassau and Suffolk Counties, and 2 boroughs of New York City—Brooklyn and Queens. The chapter’s total population is approximately 7.7 million. Membership consists of approximately 1500 pediatricians who live or practice in the region.23  AAP SONPM promotes the interests of neonatologists and pediatricians who care for newborns.24  The group is the largest subspecialty section within the AAP and represents an estimated 4500 members, or roughly 7% of all national AAP members.

To expand legislative efforts aimed at increasing state-based coverage of PDHM for hospitalized, very low birth weight (VLBW) infants, this current advocacy work aimed to create novel policy partnerships between AAP SONPM and local AAP chapters. We completed the following advocacy steps to reach our goal: creation of a state legislative toolkit to assist neonatology advocates in all aspects of this goal, including bill creation, coalition building, and passage; recruitment and pilot funding for neonatologists at academic medical centers to collaborate with local AAP Chapters; coaching and mentorship calls to support efforts; and creation of academic deliverables such as publications. The proposed outcome was drafting or passage of a bill providing Medicaid PDHM coverage within 2 years.

Beginning in 2015, New York Chapter 2 began a 2-year advocacy effort to obtain Medicaid coverage for PDHM for infants with birthweights ≤ 1500 g (VLBW infants) or known congenital intestinal conditions (Table 1). Led by an academic neonatologist who also served as the Chapter Vice-President, this effort included: recruitment of 2 key legislators (1 a scientist, the other a new mother) to codraft legislation, a press conference to push for inclusion of this provision in the state budget attended by academic neonatologists, submitted legislative testimony, a cost-effective analysis of potential savings to Medicaid, creation of a coalition of advocacy organizations interested in newborn care (March of Dimes, New York State Perinatal Association, New York State Milk Bank etc.), and drafts of letters supporting the bill to be completed by local pediatricians, private practice and academic obstetricians, neonatologists, representatives of the coalition organizations, and parental advocates.25,26 

TABLE 1

Timeline for PDHM Coverage in States Incorporating the AAP SONPM Toolkit

Organization or StateDateEvent
American Academy of Pediatrics (AAP) March 2015 AAP passes PDHM resolution #38 at Annual Leadership Forum by Shah S, Brumberg HL, and Parvez B. 
 January 2017 AAP publishes statement on PDHM Pediatrics (2017) 139(1):e20163440. 
AAP Section on Neonatal-Perinatal Medicine (AAP SONPM) March 6, 2019 AAP SONPM creates Legislative Toolkit for chapter or state use. 
 June 27, 2020 Cross Section Podcast episode released discussing need for neonatologists to advocate for PDHM coverage in state Medicaid programs. 
 January 1, 2021 Pilot advocacy grants awarded to Ohio and Georgia to advance the issue of Medicaid coverage for PDHM use. 
AAP March 29, 2021 AAP passes resolution #25 on Pediatrician role in reducing racial disparities in breastfeeding and the use of human milk by Long S, Kellams A, Ware J. 
New York February 16, 2017 New York State (NYS) Senate Bill 04526 introduced requiring Medicaid to cover PDHM for high risk infants (VLBWs and those with congenital or acquired GI lesions). 
 March 7, 2017 NYS Assembly introduces companion bill, A06481. 
 March 27, 2017 Press conference with NYS legislative leaders and bill sponsors. 
 April 9, 2017 NYS passes 2017 budget including PDHM coverage. 
 May 2017 Lead pediatricians receive State Proclamation for work on PDHM advocacy. 
 July 1, 2017 NYS Medicaid begins implementation of payment for hospitals. 
Washington (State) January 13, 2021 Neonatologists from Washington State (WA) first propose PDHM legislation using Donor Milk Toolkit. 
 July 14, 2021 WA draft bill written by Sen. Dhingra. 
 February 5, 2022 WA SB 5702 filed. 
 March 2, 2022 WA bill passes House. 
 March 7, 2022 WA bill passes Senate. 
 March 30, 2022 WA Governor signs into law. 
Maine January 11, 2021 Maine (ME) House introduces House Proposal 51. 
 April 28, 2021 ME passes House Proposal 51. 
 April 25, 2022 ME House and Senate pass 2021 version of bill LD 85. 
 May 3, 2022 ME Governor signs bill. 
Georgia March 31, 2021 Georgia (GA) House Bill 825 introduced. 
 October 14, 2021 GA Governor announces state budget will include Medicaid coverage for inpatient use of PDHM. 
 May 12, 2022 GA budget passes with short-term, dedicated funding for Medicaid coverage of PDHM. 
 July 1, 2022 GA Medicaid coverage for PDHM begins. 
Florida January 7, 2022 Florida (FL) HB1333 and companion bill SB1770 introduced for Medicaid PDHM coverage. 
 March 7, 2022 FL House of Representatives passes HB1333. 
 March 8, 2022 FL Senate passes SB1770. 
 April 6, 2022 FL Governor signs PDHM bill. 
Other   
Pennsylvania August 7, 2019 Pennsylvania Senate Bill 811 introduced. 
Ohio March 15, 2022 Ohio bill SB314 introduced for inpatient coverage. 
Organization or StateDateEvent
American Academy of Pediatrics (AAP) March 2015 AAP passes PDHM resolution #38 at Annual Leadership Forum by Shah S, Brumberg HL, and Parvez B. 
 January 2017 AAP publishes statement on PDHM Pediatrics (2017) 139(1):e20163440. 
AAP Section on Neonatal-Perinatal Medicine (AAP SONPM) March 6, 2019 AAP SONPM creates Legislative Toolkit for chapter or state use. 
 June 27, 2020 Cross Section Podcast episode released discussing need for neonatologists to advocate for PDHM coverage in state Medicaid programs. 
 January 1, 2021 Pilot advocacy grants awarded to Ohio and Georgia to advance the issue of Medicaid coverage for PDHM use. 
AAP March 29, 2021 AAP passes resolution #25 on Pediatrician role in reducing racial disparities in breastfeeding and the use of human milk by Long S, Kellams A, Ware J. 
New York February 16, 2017 New York State (NYS) Senate Bill 04526 introduced requiring Medicaid to cover PDHM for high risk infants (VLBWs and those with congenital or acquired GI lesions). 
 March 7, 2017 NYS Assembly introduces companion bill, A06481. 
 March 27, 2017 Press conference with NYS legislative leaders and bill sponsors. 
 April 9, 2017 NYS passes 2017 budget including PDHM coverage. 
 May 2017 Lead pediatricians receive State Proclamation for work on PDHM advocacy. 
 July 1, 2017 NYS Medicaid begins implementation of payment for hospitals. 
Washington (State) January 13, 2021 Neonatologists from Washington State (WA) first propose PDHM legislation using Donor Milk Toolkit. 
 July 14, 2021 WA draft bill written by Sen. Dhingra. 
 February 5, 2022 WA SB 5702 filed. 
 March 2, 2022 WA bill passes House. 
 March 7, 2022 WA bill passes Senate. 
 March 30, 2022 WA Governor signs into law. 
Maine January 11, 2021 Maine (ME) House introduces House Proposal 51. 
 April 28, 2021 ME passes House Proposal 51. 
 April 25, 2022 ME House and Senate pass 2021 version of bill LD 85. 
 May 3, 2022 ME Governor signs bill. 
Georgia March 31, 2021 Georgia (GA) House Bill 825 introduced. 
 October 14, 2021 GA Governor announces state budget will include Medicaid coverage for inpatient use of PDHM. 
 May 12, 2022 GA budget passes with short-term, dedicated funding for Medicaid coverage of PDHM. 
 July 1, 2022 GA Medicaid coverage for PDHM begins. 
Florida January 7, 2022 Florida (FL) HB1333 and companion bill SB1770 introduced for Medicaid PDHM coverage. 
 March 7, 2022 FL House of Representatives passes HB1333. 
 March 8, 2022 FL Senate passes SB1770. 
 April 6, 2022 FL Governor signs PDHM bill. 
Other   
Pennsylvania August 7, 2019 Pennsylvania Senate Bill 811 introduced. 
Ohio March 15, 2022 Ohio bill SB314 introduced for inpatient coverage. 

Based on this work, the 2017 New York State budget required payment for PDHM to VLBW infants at a rate equal to the per-ounce price from a nationally-certified not-for-profit human milk bank plus 20% for storage, handling, and logistic costs.25  New York State Medicaid, in concert with New York State neonatologists representing both private practice and academic settings, created and released implementation guidelines in November of 2017, outlining PDHM documentation requirements and the process for requesting payment.27  Yet, despite the addition of New York State, ∼70% of births remained in states without PDHM coverage.

The AAP SONPM Donor Milk Toolkit was designed to assist neonatologists by introducing specific tools related to PDHM legislation created during the New York State (NYS) experience. The toolkit included a worksheet on general advocacy principles, such as collaborating with local organizations, identifying a child-friendly legislator or Medicaid official, and a list of possible coalition partners to assist in this effort (Supplemental Information 1 and 2). Suggested partners included local hospitals, the state chapter of the American College of Obstetricians and Gynecologists, March of Dimes, practicing neonatologists, NICU quality collaboratives, pediatric gastroenterologists, midwifery organizations, local volunteer donor milk banks, and parents of premature infants who had NEC. Parents were recruited via the NEC Society, a nonprofit organization dedicated to reducing the burden of NEC, which hosts a large network of nonmedical volunteers. For interested legislators recruited by this coalition, a sample bill based on the 2017 New York State law was included to expedite bill drafting. For legislators and state Medicaid officials concerned about cost, the toolkit approximated cost-effectiveness for any state based on rates of preterm birth under Medicaid, maternal breastmilk use, medical and surgical NEC rates, and state-published NICU payments.25  A draft letter, outlining the rationale for PDHM use, adaptable either by physicians expressing support or legislators seeking cosponsorship of a bill from colleagues and/or Medicaid officials was also included. A bibliography of scientific papers was available.

To promote use of the toolkit, the AAP SONPM conducted outreach efforts to identify early-career neonatologists with an interest in advocacy. Outreach efforts included posting the pilot funding opportunity in all-section member communications and social media outlets. A podcast was recorded to review the New York State experience, discuss the urgency for other states to adopt this policy, and potentially recruit neonatology leaders in several states from either private or academic practice. AAP SONPM funded 2 pilot grants of $5000 to selected early-career neonatologists in Ohio and Georgia to advance insurance coverage of PDHM in VLBW infants, awarded after a competitive grant process. In 2019, Georgia and Ohio represented 3945 total VLBW births or 8.1% of all US VLBW births.28  Funding required partnership with the local AAP chapter, encouraged use and adaptation of the toolkit, and recommended recruitment of coalition partners. Though neonatal physicians from any practice setting were eligible, both grants were ultimately awarded to academic neonatologists. Grant funding supported time creating partnerships with coalition members suggested in the toolkit, offset any administrative support the state AAP chapter may need to assist the awardee, and supported travel to the state capital for legislative meetings and testimony. Coaching calls with AAP SONPM executive members provided guidance and tracked progress toward the deliverables, which included 2 peer-reviewed publications.20,21  To allay concerns from academic department chairs that time advocating for PDHM coverage would impede traditional work products, grantees collaborated on a peer-reviewed paper summarizing the national landscape of donor milk coverage and highlighting disparities based on Medicaid-coverage status.21  Peer-reviewed work was important to obtain support from academic chairs reluctant of allocating time for early-career faculty to work on advocacy issues. Research questions were raised during the timeline of the grant, such as determining differences in access to PDHM based on percentage of Medicaid patients served. A state-based timeline of legislative activities related to this project is shown in Table 1.

Local research demonstrated Georgia had the third highest NEC-related infant mortality in the nation, and that NEC was the ninth leading cause of infant mortality in the state, accounting for 2.3% of infant deaths.29,30  High rates of preterm birth, low rates of maternal milk usage, and racial disparities in both these areas were possible drivers of NEC rates and mortality.31,32 

Advocacy for Medicaid coverage of PDHM in Georgia relied on close collaboration between the neonatology grant recipient, other neonatal physicians, and the Georgia Chapter of the AAP (GA AAP) and included adaptation of the toolkit for local use. GA AAP identified local legislators and officials supportive of the bill and created a legislative strategy for passage. Presentations to the Chapter’s Legislative Committee and Committee on the Fetus and Newborn recruited general pediatricians to the coalition.

AAP SONPM grant funds supported chapter staff in advocacy efforts and allowed for the creation of a single page handout for dissemination to legislators and department leaders (Fig 1). This handout used the format of the chapter’s prior advocacy tools, and thus was a familiar format to legislators. Five bulleted points outlining the case for Medicaid reimbursement in Georgia were included: (1) education on prematurity and human milk, (2) a direct request for Medicaid reimbursement, (3) relevance to Georgia’s families, (4) the cost of NEC, and (5) potential cost-savings and life impact of providing PDHM. Adapted from the toolkit’s cost-effectiveness worksheet, advocates calculated the potential cost-savings of PDHM using Georgia-specific VLBW births, local PDHM use rates, and cost per ounce of PDHM from a local milk bank (Fig 1).

FIGURE 1

American Academy of Pediatrics Georgia chapter one page summary of Medicaid coverage for donor milk, including sample cost effective calculations take from reference 25 .

FIGURE 1

American Academy of Pediatrics Georgia chapter one page summary of Medicaid coverage for donor milk, including sample cost effective calculations take from reference 25 .

Close modal

Efforts in Georgia involved both the state’s legislative and executive branches. State lawmakers introduced House Bill 825 at the end of the 2020 to 2021 legislative session, establishing the fiscal request for PDHM payment.33  With the bill introduced but awaiting the start of the 2021 to 2022 legislative session for consideration, GA AAP advocated directly with the Department of Community Health, which oversees the state’s Medicaid program, and the Governor’s office to earmark $469 138 for Medicaid PDHM reimbursement in the 2023 state budget. Work with state Medicaid officials and NICUs continues to create a framework for implementation.

Though Washington State was not selected for receipt of pilot grant funds, use of the AAP SONPM Toolkit assisted with identifying coalition partners in Washington State, including the Healthcare Coalition for Children and Youth, the local Washington State AAP Chapter, and a local human milk bank. Led by an academic neonatologist, outreach to the Office of the Insurance Commissioner requesting PDHM coverage via regulatory authority occurred in the spring 2021 while coalition partners simultaneously identified a legislative sponsor. State Senator M. Dingra, who serves on the state’s Ways and Means Committee, introduced Washington State Senate Bill 5702 in January of 2022. Washington State used the toolkit’s draft letters of support for insurance coverage of PDHM use. Similar to the Georgia experience, a 1-page summary abbreviated the legislative request, key data points, and estimated impact on babies statewide. Documentation of other states with similar legislation was particularly beneficial.

Cost-effective calculations provided in the tool kit were of limited benefit in Washington State, as the coalition’s eligibility requirements for insurance-covered PDHM use extended beyond the VLBW population (Table 2). Unlike the legislative strategy in New York, which focused heavily on the cost-savings argument and thus reserved donor milk for babies at highest risk for NEC, Washington State’s approach emphasized health equity as the primary rationale for this coverage.25,35  Support for SB 5702 was considered a potential redress of racial and socioeconomic disparities in access to breastmilk and breastfeeding support. Advocates emphasized geographic variations in PDHM access, with decreased availability in rural birthing hospitals. With an estimated 15% of infants in the state receiving formula in the first 48 hours of life, overwhelmingly from mothers with labor complications who delivered via Cesarean section, Washington’s State’s coalition promoted PDHM coverage as a vehicle for maternal equity. Failure to support the bill was framed as penalizing infants born to mothers with delivery complications. Support for the measure benefitted from a greater statewide focus on maternal and infant supports occurring concurrently, including expanding postpartum Medicaid coverage to 1 year after delivery and broadening insurance support for lactation services. The law passed on March 30, 2022.36 

TABLE 2

Medical Indications for Inpatient Infants Requiring Third-Party Payment for Use of Pasteurized Human Donor Milk in Washington State (as Proposed in Washington State Bill 5702)

Indications for Insurance Coverage of Inpatient Donor Milk in Washington State
Infants < 2500 g 
Infants 34 wk GA or less 
At risk for BPD, ROP, or NEC 
Congenital or acquired GI condition predisposing to long-term feeding or malabsorption complications 
Sepsis 
Organ or bone marrow transplant 
Congenital hypotonia associated with feeding difficulty or malabsorption 
Renal dialysis requiring dialysis in the first year of life 
Craniofacial anomalies 
Immunologic deficiencies 
Neonatal abstinence syndrome 
“Any other serious congenital or acquired condition for which the use of donor human milk and donor human milk derived products is medically necessary and supports the treatment and recovery of the child.” 
“Any baby still inpatient within 72 hours of birth without sufficient milk available.” 
Indications for Insurance Coverage of Inpatient Donor Milk in Washington State
Infants < 2500 g 
Infants 34 wk GA or less 
At risk for BPD, ROP, or NEC 
Congenital or acquired GI condition predisposing to long-term feeding or malabsorption complications 
Sepsis 
Organ or bone marrow transplant 
Congenital hypotonia associated with feeding difficulty or malabsorption 
Renal dialysis requiring dialysis in the first year of life 
Craniofacial anomalies 
Immunologic deficiencies 
Neonatal abstinence syndrome 
“Any other serious congenital or acquired condition for which the use of donor human milk and donor human milk derived products is medically necessary and supports the treatment and recovery of the child.” 
“Any baby still inpatient within 72 hours of birth without sufficient milk available.” 

BPD, bronchopulmonary dysplasia; GA, gestational age; GI, gastrointestinal; NEC, necrotizing enterocolitis; ROP, retinopathy of prematurity.

Though actively opposed by the coalition in Washington State, the law allowed for prior authorization for PDHM at the discretion of a covering health plan. Further, outpatient PDHM coverage, though a major aim of the coalition, remained unaddressed. Negotiations regarding reinvestment of cost-savings from PDHM use in VLBW babies into outpatient coverage are ongoing and remain an advocacy goal. Neonatal advocates’ current agenda includes implementation of billing and reimbursement models for hospital use, as well as creating a state-wide mechanism for evaluating use and public health benefits. Even among states passing similar legislation decades ago, billing and reimbursement strategies remain opaque, especially given the absence of billing codes for provision of PDHM. Sharing experiences on how states operationalize hospital payment is a crucial next step to assist with making PDHM routine.

The Ohio coalition for donor milk coverage, convened and led by an academic neonatologist, used the AAP SONPM Tookit to recruit coalition partners, including: the offices of government relations at several Ohio-based children’s hospitals, the Ohio Children’s Hospital Association, a state Medicaid director, a state milk bank, and neonatologists at other institutions. The included letter of endorsement provided talking points for nonclinical partners and the cost-analysis calculator estimated the long-term cost savings of PDHM use. Utilization of the kit was paired with access to other leaders in the field who provided expertise and support throughout the advocacy journey, including assistance with opinion-editorial writing and media interviews. Hospital dieticians, milk technicians (who order and track PDHM use from the state milk bank), business directors, payer relations officials (who create the infrastructure needed to code and bill for inpatient PDHM use), local lactation consultants and scientific researchers comprised additional recruited coalition members.

Ohio Senate Bill 314 was introduced in March 2022.37  As currently written, SB 314 would make inpatient donor milk a covered benefit by all payers for high-risk infants with medical necessity. Prior authorization would, like Washington State, be at the discretion of the health plan. Eligibility criteria are similar to the expanded criteria used in Washington State (Table 2). Outpatient donor milk has been a covered benefit for medically-eligible Medicaid enrollees under Ohio rule 5160-10-26 since 2018.

Encouraged by these efforts, other state coalitions formed, seeking PDHM coverage. Led by neonatologists and local AAP chapters, several states engaged in successful advocacy campaigns. Adapting resources created by other states, Maine obtained third-party PDHM coverage on May 3, 2022, impacting up to 150 VLBW babies per year.38  Buoyed by the increasing number of bills passing in states with fewer births, Florida - which has up to 3200 VLBW infants annually out of a total of ∼220 000 births - signed SB1770/HR1333 into law on April 6, 2022, providing PDHM coverage to inpatient VLBW babies.39 

This case study demonstrates how pediatric subspecialists, by collaborating with subspecialty-focused organizations, can advance niche advocacy issues at the state level. This is important as pediatric subspecialty concerns are normally not the priority of state-based advocacy agendas, as medical societies emphasize topics that are broader across pediatric and medical practice. Further, it provides a template that subspecialty organizations may apply to leverage policy achievements in one state and export them to another, expanding influence and benefit for children.

Pilot grant funding helped identify passionate subspecialist advocates, incentivized use of the donor milk toolkit, and assisted early-career academic neonatologists in obtaining protected time to achieve advocacy deliverables – which in our case included a draft bill or similar regulation. Provision of other work products, such as review-articles, podcast appearances, and policy commentaries also allowed for grantees to work on the issue of PDHM coverage while demonstrating academic productivity. Within pediatrics, there is greater recognition of advocacy as scholarly work, and this project demonstrated to institutional leadership how to incorporate advocacy into an academic model.40,41  Review articles that summarize the current environment for an issue such as access to donor milk and prescribing potential policy remedies can be submitted for peer-review. Deliverables during this project also included transcripts of testimony, documentation of legislative meetings, and the 1-page summaries previously described. As this case demonstrates, if advocacy is to be truly supported among academic children’s hospitals, institutional understanding of the scholarly nature of the work is essential.

This framework thus provides support from division heads and contextualizes advocacy work as a scholarly pursuit equivalent to teaching, research, or other academic endeavors. Frequent coaching calls helped grant awardees build coalitions and ensured monthly progress. Involvement with the local AAP chapter, a requirement for grant funding, allowed grantees and others who used the toolkit to access local expertise and brought increased awareness of PDHM coverage issues to AAP chapters often focused on goals aligned with general pediatric practice. Allying with patient organizations expanded the advocacy coalition beyond neonatologists and pediatricians to include allied health professions such as dieticians and midwives, as well as parents impacted by NEC. Partnerships also helped craft the most persuasive local rationale for PDHM coverage, which varied from improving equity in one state to financial cost-savings in others. Further, since subspecialty physician networks can be relatively small, work in our initial 2 states quickly grew to 3 others, demonstrating the exponential benefit of this program.

As cost-savings data from states begin to be widely shared, interest in PDHM coverage has increased. Currently the National Association of Medicaid Directors has requested access to the cost modeling in the toolkit, which may hasten adoption via regulations without requiring neonatal legislative advocacy. The AAP SONPM is considering providing an additional year of funding to neonatologists in Ohio to continue to advance PDHM coverage. Funding is also being considered for Georgia to codify Medicaid coverage of PDHM in legislation, as the current process includes discretionary funding.

Building on state-based work, Representative Chrissy Houlahan (D-PA) has introduced the bipartisan Access to Donor Milk Act to expand access to and awareness of PDHM.42  Though not mandating national coverage of PDHM by health insurers, the measure would provide emergency funding for donor milk banks to meet any rapid increase in demand associated with passage of PDHM Medicaid coverage in any given state. This bill provides a national forum for advocacy by all those impacted by NEC with potential benefit for all VLBW children and supplements state-based actions.

This experience has demonstrated a roadmap to activate state advocacy among neonatologists and other subspecialists. Other subspecialty sections or independent organizations should use this roadmap to advance state-based issues related to their specific field. The AAP SONPM is also considered using the same model to recruit neonatologists interested in advancing the duration of postpartum Medicaid coverage to 12 months in states which do not currently have such provisions.

The authors acknowledge the support of the American Academy of Pediatrics Section on Neonatal-Perinatal Medicine for assistance with creation and dissemination of the toolkit described in this paper.

Dr Shah conceptualized the paper, drafted the initial manuscript, and reviewed and revised the manuscript; Drs Miller and Rose made critical revisions of the manuscript, assisted significantly in the advocacy outlined in the paper, and reviewed the manuscript; Dr Perez made critical revisions of the manuscript, assisted significantly in the advocacy outlined in the paper and reviewed the manuscript; and all authors approve the final manuscript as submitted.

FUNDING: Drs Miller and Rose were supported by a small grant from the American Academy of Pediatrics Section on Neonatal-Perinatal Medicine.

CONFLICT OF INTEREST DISCLOSURES: The authors have indicated they have no conflicts of interest relevant to this article to disclose.

AAP

American Academy of Pediatrics

AAP SONPM

American Academy of Pediatrics Section on Neonatal-Perinatal Medicine

NEC

necrotizing enterocolitis

PDHM

pasteurized donor human milk

VLBW

very low birth weight

1
Committee on Nutrition
;
Section on Breastfeeding
;
Committee on Fetus and Newborn
.
Donor human milk for the high-risk infant: preparation, safety, and usage options in the United States
.
Pediatrics
.
2017
;
139
(
1
):
e20163440
2
Cristofalo
EA
,
Schanler
RJ
,
Blanco
CL
, et al
.
Randomized trial of exclusive human milk versus preterm formula diets in extremely premature infants
.
J Pediatr
.
2013
;
163
(
6
):
1592
1595.e1
3
O’Connor
DL
,
Gibbins
S
,
Kiss
A
, et al;
GTA DoMINO Feeding Group
.
Effect of supplemental donor human milk compared with preterm formula on neurodevelopment of very low-birth-weight infants at 18 months: a randomized clinical trial
.
JAMA
.
2016
;
316
(
18
):
1897
1905
4
Cognata
A
,
Kataria-Hale
J
,
Griffiths
P
, et al
.
Human milk use in the preoperative period is associated with a lower risk for necrotizing enterocolitis in neonates with complex congenital heart disease
.
J Pediatr
.
2019
;
215
:
11
16.e2
5
Hoban
R
,
Khatri
S
,
Patel
A
,
Unger
SL
.
Supplementation of mother’s own milk with donor milk in infants with gastroschisis or intestinal atresia: a retrospective study
.
Nutrients
.
2020
;
12
(
2
):
589
6
McCune
S
,
Perrin
MT
.
Donor human milk use in populations other than the preterm infant: a systematic scoping review
.
Breastfeed Med
.
2021
;
16
(
1
):
8
20
7
Jones
IH
,
Hall
NJ
.
Contemporary outcomes for infants with necrotizing enterocolitis-a systematic review
.
J Pediatr
.
2020
;
220
:
86
92.e3
8
Zozaya
C
,
García González
I
,
Avila-Alvarez
A
, et al
.
Incidence, treatment, and outcome trends of necrotizing enterocolitis in preterm infants: a multicenter cohort study
.
Front Pediatr
.
2020
;
8
:
188
9
Henry
MC
,
Moss
RL
.
Neonatal necrotizing enterocolitis
.
Semin Pediatr Surg
.
2008
;
17
(
2
):
98
109
10
Yee
WH
,
Soraisham
AS
,
Shah
VS
,
Aziz
K
,
Yoon
W
,
Lee
SK
;
Canadian Neonatal Network
.
Incidence and timing of presentation of necrotizing enterocolitis in preterm infants
.
Pediatrics
.
2012
;
129
(
2
):
e298
e304
11
Flahive
C
,
Schlegel
A
,
Mezoff
EA
.
Necrotizing enterocolitis: updates on morbidity and mortality outcomes
.
J Pediatr
.
2020
;
220
:
7
9
12
Bazacliu
C
,
Neu
J
.
Necrotizing enterocolitis: long term complications
.
Curr Pediatr Rev
.
2019
;
15
(
2
):
115
124
13
Mowitz
ME
,
Dukhovny
D
,
Zupancic
JAF
.
The cost of necrotizing enterocolitis in premature infants
.
Semin Fetal Neonatal Med
.
2018
;
23
(
6
):
416
419
14
Johnson
TJ
,
Patel
AL
,
Jegier
BJ
,
Engstrom
JL
,
Meier
PP
.
Cost of morbidities in very low birth weight infants
.
J Pediatr
.
2013
;
162
(
2
):
243
49.e1
15
Stey
A
,
Barnert
ES
,
Tseng
CH
, et al
.
Outcomes and costs of surgical treatments of necrotizing enterocolitis
.
Pediatrics
.
2015
;
135
(
5
):
e1190
e1197
16
Miller
J
,
Tonkin
E
,
Damarell
RA
, et al
.
A systematic review and meta-analysis of human milk feeding and morbidity in very low birth weight infants
.
Nutrients
.
2018
;
10
(
6
):
707
17
Arslanoglu
S
,
Corpeleijn
W
,
Moro
G
, et al;
ESPGHAN Committee on Nutrition
.
Donor human milk for preterm infants: current evidence and research directions
.
J Pediatr Gastroenterol Nutr
.
2013
;
57
(
4
):
535
542
18
Kantorowska
A
,
Wei
JC
,
Cohen
RS
,
Lawrence
RA
,
Gould
JB
,
Lee
HC
.
Impact of donor milk availability on breast milk use and necrotizing enterocolitis rates
.
Pediatrics
.
2016
;
137
(
3
):
e20153123
19
Quigley
M
,
Embleton
ND
,
McGuire
W
.
Formula versus donor breast milk for feeding preterm or low birth weight infants
.
Cochrane Database Syst Rev
.
2019
;
7
(
7
):
CD002971
20
Shah
S
,
Miller
ER
.
Advocating for donor milk access in Medicaid: bringing equity to the neonatal intensive care unit
.
Pediatr Res
.
2022
;
91
(
1
):
14
16
21
Rose
AT
,
Miller
ER
,
Butler
M
, et al
.
US state policies for Medicaid coverage of donor human milk
.
J Perinatol
.
2022
;
42
(
6
):
829
834
22
Shah
S
,
Brumberg
HL
,
Parvez
B
.
Health insurance coverage for donor human milk in preterm infants with birth weights ≤1500 grams
.
23
Shah
SI
,
Siddiqui
S
,
Krief
EM
.
Restricting the sale of electronic nicotine celivery system flavors
.
Pediatrics
.
2021
;
148
(
3
):
e2021051223
24
American Academy of Pediatrics Section on Neonatal-Perinatal Medicine
.
Mission, goals, core values, and strategic plan
.
25
Schmaltz
CH
,
Bouchet-Horwitz
J
,
Summers
L
.
Advocating for pasteurized donor human milk: the journey for Medicaid reimbursement in New York State
.
Adv Neonatal Care
.
2019
;
19
(
6
):
431
440
26
Kemp Hannon
.
Senator Hannon holds a news conference to support donor milk legislation
.
Available at: https://www.youtube.com/watch?v=qt4E0zCrtNA. Accessed December 7, 2022
27
New York State
.
New York state Medicaid reimbursement for pasteurized donor human milk
.
New York State Medicaid Update
.
2017
;
33
(
11
)
28
March of Dimes
.
Peristats
.
Available at: https://www.marchofdimes.org/peristats/. Accessed December 7, 2022
29
Wolf
MF
,
Rose
AT
,
Goel
R
,
Canvasser
J
,
Stoll
BJ
,
Patel
RM
, editors.
Infant Mortality in the United States due to Necrotizing Enterocolits, 1999-2017: Trends and Racial and Geographic Disparities (abstract 3378532)
.
Philadelphia, PA
:
Pediatric Academic Societies
;
2020
30
Health
P
;
Georgia Department of Public Health
.
Reducing infant mortality in Georgia 2013 annual report
.
31
Division of Nutrition, Physical Activity, and Obesity
,
Centers for Disease Control and Prevention
.
Breastfeeding report card United States, 2020
.
32
Chiang
KV
,
Li
R
,
Anstey
EH
,
Perrine
CG
.
Racial and ethnic disparities in breastfeeding initiation — United States, 2019
.
MMWR Morb Mortal Wkly Rep
.
2021
;
70
(
21
):
769
774
33
Cooper
S
,
Dempsey
K
,
Parrish
B
,
Smith
L
,
Stephens
R
.
Georgia House Bill 825: Medicaid coverage for medically necessary donor human milk
.
Available at: https://www.billtrack50.com/BillDetail/1353117. Accessed December 7, 2022
34
Dingra
M
.
An Act relating to requiring coverage for donor breast milk; amending RCW 41.05.017; adding a new section to chapter 48.43 RCW; and adding a new section to chapter 74.09 RCW
.
Washington State Senate Bill 5702, 2022 Regular Session. Available at: https://lawfilesext.leg.wa.gov/biennium/2021-22/Pdf/Bills/Senate%20Bills/5702.pdf?q=20221208121519. Accessed December 8, 2022
35
Solages
M
.
Establishes protocol for financial reimbursement for donor human breast milk
.
New York State Assembly Bill A06163, 2017 Legislative Session. Available at: https://nyassembly.gov/leg/?default_fld=&leg_video=&bn=A06163&term=2017&Summary=Y&Text=Y. Accessed December 7, 2022
36
Washington State Legislature
.
SB 5702. Bill history
.
37
Maharath
T
,
Antonio
NJ
,
Yuko
K
.
To enact sections 3701.62, 3902.63, and 5164.072 of the Revised Code to require health benefit plan and Medicaid coverage of medically necessary donor human milk
.
Ohio Senate Bill 314, 134th General Assembly. Available at: https://search-prod.lis.state.oh.us/solarapi/v1/general_assembly_134/bills/sb314/IN/00/sb314_00_IN?format=pdf. Accessed December 8, 2022
38
Craven
M
.
An act concerning Maine care coverage for donor breast milk
.
House Proposal 51. 130th Maine Legislature, 2022. Available at: https://trackbill.com/bill/maine-legislative-document-85-an-act-concerning-mainecare-coverage-for-donor-breast-milk/1974998/. Accessed December 8, 2022
39
Book
L
.
An act relating to donor human milk bank services; amending s. 409.906, F.S.; authorizing the Agency for Health Care Administration to pay for donor human milk bank services as an optional Medicaid service if certain conditions are met; specifying coverage requirements; amending s. 409.908, F.S.; adding donor human milk bank services to the list of Medicaid services authorized for reimbursement on a fee-for service basis; amending s. 409.973, F.S.; adding donor human milk bank services to the list of minimum benefits required to be covered by Medicaid managed care plans; providing an effective date
.
Florida Senate Bill 1770, 2022. Available at: https://www.flsenate.gov/Session/Bill/2022/1770/BillText/Filed/HTML. Accessed December 7, 2022
40
Shah
S
,
Brumberg
HL
,
Kuo
A
,
Balasubramaniam
V
,
Wong
S
,
Opipari
V
.
Academic advocacy and promotion: how to climb a ladder not yet built
.
J Pediatr
.
2019
;
213
:
4
7.e1
41
Shah
SI
,
Brumberg
HL
.
Advocating for advocacy in pediatrics: supporting lifelong career trajectories
.
Pediatrics
.
2014
;
134
(
6
):
e1523
e1527
42
Houlahan
C
.
To protect and expand access to donor milk, and for other purposes
.
House Resolution 9196, 117th Congress. Available at: https://www.congress.gov/117/bills/hr9196/BILLS-117hr9196ih.pdf. Accessed April 19, 2023

Supplementary data